Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06661603

Effect of Practicing Yoga and Meditation on Cortisol Hormone, Immunoglobulin A and Metabolic Parameter Among Medical Students

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
280 (estimated)
Sponsor
University of Pecs · Academic / Other
Sex
All
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

This clinical trial aims to develop and test a yoga intervention to improve cortisol hormone rhythm, immunoglobulin A, and metabolic markers among medical students. The development of the yoga protocol, "GSY Goodbye Stress with Yoga Proto-col," was a collaborative effort involving a certified yoga trainer, medical researcher, and experienced yogis from India. GSY yoga intervention, which includes yoga asanas poses, breathing techniques, and guided meditation, may reduce stress levels, improve immunity, and enhance other metabolic parameters in medical students.

Detailed description

PRIMARY OBJECTIVE: 1. To examine the effectiveness of yoga intervention as a stress reduction technique and measure its effects on the level of cortisol, immunoglobulin A (IgA), and metabolic parameters. 2. To Compare the outcomes of a yoga intervention group to a non-yoga intervention group to determine whether practicing yoga can reduce the negative impacts of elevated cortisol on the physiological parameters. SECONDARY OBJECTIVES: 1. To determine the correlation between the psychophysiological stress and cortisol hormone in students. 2. To investigate the effect of yoga intervention on student mental health and well-being. OUTLINE: Participants receive yoga intervention from a certified yoga trainer once a week for 10 weeks.

Conditions

Interventions

TypeNameDescription
BEHAVIORALGSY Yoga InterventionIn the GSY yoga intervention, where participants received 90 minutes/week yoga intervention for duration of 10 weeks.

Timeline

Start date
2022-02-07
Primary completion
2025-06-01
Completion
2025-07-01
First posted
2024-10-28
Last updated
2024-12-09

Locations

1 site across 1 country: Hungary

Source: ClinicalTrials.gov record NCT06661603. Inclusion in this directory is not an endorsement.